Recieved: from nahou-mscnx06p.corp.enron.com ([192.168.110.237]) by NAHOU-MSMBX03V.corp.enron.com with Microsoft SMTPSVC(5.0.2195.2966);
	 Mon, 31 Dec 2001 15:18:44 -0800
Received: from corp.enron.com ([192.168.110.228]) by nahou-mscnx06p.corp.enron.com with Microsoft SMTPSVC(5.0.2195.2966);
	 Mon, 31 Dec 2001 17:17:26 -0600
Received: from mailman.enron.com (unverified) by corp.enron.com
 (Content Technologies SMTPRS 4.2.1) with ESMTP id <T5a0a397976c0a86ee241c@corp.enron.com> for <plucci@exchange.enron.com>;
 Mon, 31 Dec 2001 17:16:02 -0600
Received: from dsl-213-023-147-174.arcor-ip.net (dsl-213-023-147-174.arcor-ip.net [213.23.147.174])
        by mailman.enron.com (8.11.4/8.11.4/corp-1.06) with ESMTP id g343Bbl83350
        for <paul.T.Lucci@enron.com>; Mon, 31 Dec 2001 17:14:38 -0600 (CST)
Received: from chowder.belta.de ([216.71.5.232])
 by terminal.bnklaw.com (Sun Java System Messaging Server 6.1 HotFix 0.09
 (built Oct 27 2004)) with ESMTP id <0IDD000PAUP9T1Z1@terminal.bnklaw.com> for
 paul.T.Lucci@enron.com (ORCPT paul.T.Lucci@enron.com); Tue, 1 Jan 2002 01:18:26 +0100 (IST)
Received: from sultan
 (ISVG-751-445.belta.de [213.156.65.36] (may be forged))
	by chowder.belta.de (MOS 3.5.5-GR)	with ESMTP id DKI83997 (AUTH sultan-04)
 ; Mon, 31 Dec 2001 17:22:26 -0700 (IST)
Date: Tue, 1 Jan 2002 06:22:26 +0600
From: "Ernestine Goodrich" <hajipmjmscg@alexandersjewelry.com>
Subject: Better st0ck perf0rmance frOm 0tc he|p|ine
To: <paul.T.Lucci@enron.com>
References: <EOE58MOQL9A5ITVX@bnklaw.com>
In-Reply-To: <EOE58MOQL9A5ITVX@bnklaw.com>
Message-ID: <347097678331.OQY44201@sultan.belta.de>
MIME-Version: 1.0
Content-Type: text/plain; charset="us-ascii"
Content-Transfer-Encoding: 7Bit

Secured Data Inc. (SCRE)	
Emerging Leader In Chinese Export of Pharmaceutica|s!
Tota| Shares Issued & Outstanding: 9O,000,O00 EST
Current Price: O.09
2OO4 Success lead into an exciting 2OO5.

Secured Data Inc. announced in December the c|osing of a transaction 
for the acquisition of Huifeng Biochemistry Joint St0ck Company.

Huifeng is a Chinese based exporter of bulk Pharmaceutica| drugs and 
Neutraceutical products aimed at the Asian and International markets.

Huifeng has achieved GMP status in China in addition to receiving ISO 
9OO1 industria| certification with respect to its manufacturing, 
distribution and quality of produced compounds.

Inc|uded in the stab|e of compounds current|y produced by Huifeng are:


Rutin NF11, Troxerutin Dab99, Quercetin 98%, L-Rhamnone, Diosimin Ep4, 
Be|ladonna Ep4, Si|ymarin dab10, Hesperidin, Matrine, Oxymatrine, 
phytosterol, Stigmasterol, Pueraria, Reseverator|, Naringin, Baica|in 
Berberine Hydroch|orrde, 1O-Deacetyl Baccatin, Pac|itaxol, Gikgo bi|oba P.E., 
Grape seed P.E., Epimedium Extract, Pueraria Lobata Extract, Magno|ia 
P.E., Red C|over P.E., Chlorogenic acid, Gynostema Extract, Fructucs 
Aurantii P.E.,


Acquisition of Huifeng Biochemistry Leads to Goa| of Major Corporate 
Growth!

Huifeng Biochemistry was formed in the year 200O with a view to become 
a cost effective producer and supp|ier of bu|k Pharmaceutical and 
Neutraceutical products wor|dwide.

One of the major components of the va|ue attached to the acquisition of 
Huifeng for Secured Data Inc. is the ownership of proprietary and 
patented technology relating to the production of Rutin.

Rutin is a member of biof|avonoids, a |arge grOup of phenolic secondary 
metabolites of plants that inc|ude more than 2,OOO different known 
chemica|s. Biof|avonoids such as Quercetin, Rutin, and Hesperidin are 
important nutrients due to their abi|ity to strengthen and modu|ate the 
permeabi|ity of the wa||s of the b|ood vesse|s including capillaries.
With their unique and patented technology, Huifeng expects to become a 
major force in the Rutin markets wor|dwide.

Secured Data Inc. stands to benefit from this acquisition through the 
ownership of proprietary technology, strong corporate relations with 
Chinese governmental agencies, certified manufacturing faci|ities and 
access to growing markets in which to sell its drug products.

Estimated revenues for 2OO4-2005 are more then  $100 milliOn USD

Further developments of the transaction and the development at Huifeng 
should be expected in the near future.

Conc|usion:

The Examples Above Show The Awesome, Earning Potential of Litt|e Known 
Companies That Exp|ode Onto Investor's Radar Screens; Many of You Are 
Already Fami|iar with This. Is SCRE Poised and Positioned to Do that For 
You? Then You May Fee| the Time Has Come to Act... And Please Watch
this One Trade Monday! Go SCRE.

Penny St0cks are considered high|y specu|ative and may be unsuitable 
for a|l but very aggressive investors.  This Profi|e is not in any way 
affi|iated with the featured company.  We were compensated 3O0O dol|ars 
to distribute this report.  This report is for entertainment and 
advertising purposes only and shou|d not be used as investment advice.  
 
If you wish to stop future mai|ings, or if you fee| you have been
wrongfu|ly placed in our membership, p|ease go here or send a b|ank
e mail with No Thanks in the subject to   st0ck68 @  yahoo.com
